GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Price-to-Funds-From-Operations

Celltrion (XKRX:068270) Price-to-Funds-From-Operations : (As of Jun. 05, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Celltrion (XKRX:068270) Business Description

Industry
Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.